Article info

Original research
Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer

Authors

  1. Correspondence to Dr Mark M. Awad; mark_awad{at}dfci.harvard.edu
View Full Text

Citation

Alessi JV, Ricciuti B, Alden SL, et al
Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer

Publication history

  • Accepted November 2, 2021
  • First published November 25, 2021.
Online issue publication 
May 08, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.